2. ContentsContents
Def init ion
Hist ory
Classif icat ion
I ndicat ions
Pret reat ment evaluat ion
Medical & Dent al hist ory
Cont raindicat ions
Clinical examinat ion
Radiographic examinat ion
conclusion
3. DefinitionDefinition
Implantation is defined as the
insertion of any object or material,
such as an alloplastic substance
or other tissue, either partially or
completely, into the body for
therapeutic, diagnostic, prosthetic
or experimental purposes.
4. HISTORYHISTORY
Carved bamboo pegs were used
4000yrs ago in China
Root form metal pegs- Egypt 2000
yrs back
Archaeological museum at
Harvard houses an implant made
of shell dating back to 600 AD
Albucasise de condue (1963-
1013) used ox bone , first
5. •Per Ingvar Branemark
- Osseo integration
•1965- first titanium dental
implant placed in a human
volunteer.
X ray of titanium chamber embedded
in rabbit femur
Panoramic radiograph of historic
dental implants, taken 1978
9. Why implants??Why implants??
Maintains bone
Restore and maintain occlusal vertical
dimensions
Improves esthetics,phonetics,occlusion
Improves masticatory function
Improves psychological health
10. Pre treatment evaluationPre treatment evaluation
Chief complaint -
Pat ient ’s concern
Pat ient ’s expect at ion
11. Medical historyMedical history
Thorough medical history should be
documented.
Review for conditions that might pose a
risk for adverse reactions/complications.
Laboratory tests to rule out conditions
that might be contraindication/risk
factor.
Medical clearance from treating
physician.
12. ASA PHYSICAL STATUSASA PHYSICAL STATUS
CLASSIFICATIONCLASSIFICATION
ASA I - A normal healthy patient without systemic
disease
ASA II- A patient with mild systemic disease
ASA III- A patient with severe systemic disease
that limits activity but is not incapacitating
ASA IV- A patient with an incapacitating systemic
disease that is a constant threat to life.
ASA V- A moribund patient not expected to
survive 24 hours without operation
ASA E- Emergency operation
13. ContraindicationsContraindications
Medical
• acute infectious diseases
– absolute, but temporarily; wait for
recovery
• chemotherapy
– absolute, but temporarily; reduced
immune status
• systemic bisphosphonate medication
(≥2 yr)
– risk of bisphosphonate-induced
osteonecrosis (BON)
• renal osteodystrophia
– increased risk for infection, reduced
bone density
• severe psychosis
– absolute; risk of regarding the
implant as foreign body and
requesting removal despite of
successful osseointegration
• depression – relative
NU Zitzman et al Australian Dental Journal 2008; 53:(1 Suppl):
S3–S10
14. • pregnancy
– absolute, but temporarily; to avoid
additional stress and radiation
exposure
• unfinished cranial growth with
incomplete tooth eruption
– relative, but temporarily; to avoid
any harm to the growth plates, to
avoid inadequate implant position in
relation to the residual dentition
intraoral
• pathologic findings at the oral soft-
and/or hard tissues
– temporarily; increased risk for
infection, wait until healing is
completed
NU Zitzman et al Australian Dental Journal 2008; 53:(1
Suppl): S3–S10
15. Increased risk
post head and neck radiation therapy
– reduced bone remodelling, risk of
osteoradionecrosis, implant
placement 6–8 weeks before or ≥1 yr
after radiotherapy
• osteoporosis – reduced bone to implant contact
• uncontrolled diabetes
– wound healing problems (impaired
immunity, microvascular diseases)
• status post chemotherapy, immuno-
suppressants or steroid long-term
medication, HIV infection
– wound healing problems, medical
advice required
• alcohol and drug abuse, heavy
smoking ≥20 cig/d
– wound healing problems, locally
reduced vascularization7
• history of aggressive periodontitis
– increased risk to develop peri-
implantitis
NU zitzman et al Australian Dental Journal 2008;
53:(1 Suppl): S3–S10
16. Habits and behavioral considerationsHabits and behavioral considerations
◦ Smoking & tobacco use
*Adversely affects implant success through
its effect on bone metabolism
◦ Para functional habits
* Repeated lateral forces can be detrimental
to osseointegration process.
◦ Substance abuse
* Psychological problems , non
compliance
* Impaired organ function
17. Dental historyDental history
Oral hygiene status and
practices
Compliance with past dental
recommendations
Previous experience with
surgery and prosthetics
Attitude and motivation
towards implants
21. Hard tissue evaluationHard tissue evaluation
Clinically and radiographically
Palpate for anatomical defects,
concavities and undercuts
Intraoral bone mapping
22. Evaluation of implant sitesEvaluation of implant sites
Alveolar bone
Atleast 1.0 to 1.5mm of
bone around implant
Interdental space
Buccolingual width >
6mm
24. Diagnostic study modelsDiagnostic study models
Evaluate space available
Determine potential limitations of planned
treatment
Useful while replacing multiple teeth or in case
of malocclusion.
25. Radiographic examinationRadiographic examination
Quality, quantity and location and volume of alveolar
bone
Identify vital structures: floor of nasal cavity, maxillary
sinus, mandibular canal, mental foramen
Radio opaque markers can be used to evaluate
relation of alveolar ridge to existing teeth
27. INDICATIONS ADVANTAGES LIMITATIONS
PERIAPICAL
RADIOGRAPHY
Small edentulous
spaces, alignment and
orientation during
surgery
Low radiation dose ;
inexpensive
Minimal site
evaluation; distortion
& magnification
OCCLUSAL
RADIOGRAPHY
none Evaluation of
pathology
Does not reveal true
buccolingual width:
Difficulty in
positioning
CEPHALOMETRIC
RADIOGRAPHY
Used with other
radiographs for
anterior implants
Low magnification;
Height/width in
anterior region
Limited to midline;
reduced sharpness &
resolution
PANORAMIC
RADIOGRAPHY
Commonly used Initial assessment of
vertical bone height;
Gross anatomy &
pathology evaluation
Distortion; does not
demonstrate bone
quality
COMPUTED
TOMOGRAPHY
Determination of
bone density; vital
structure location;
determination of
pathology
Negligible
magnification; high
contrast image; 3D;
Various views
Cost; technique
sensitive
28. Laboratory testsLaboratory tests
Complete blood count
WBC- 4,000 to 11,000 cells/mm3
RBC- 4-6 million/mm3
Platelet- 1,50,000- 4,00,000cells/mm3
MCV- 80-100 fL
MCHC- 32 to 36 g/dL
hemoglobin- 11- 16 g/dL
Prothrombin time- INR (normal range- 0.8 to 1.2)
Glycemic control- HbA1c (4 to 6%)
Thyroid function tests- T3- 60 to 175 µg/dl
T4- 4-11 ng/dl
29. ConclusionConclusion
The success and predictability of dental
implants have changed philosophy and
practice of dentistry.
However, proper pre treatment
evaluation, and a treatment plan are
imperative for its success.
30. ReferenceReference
Contemporary implant dentistry, 3rd
ed,
Carl E Misch
Carranza’s clinical periodontology, 10th
ed.
Phillips’ science of dental materials,
11th
ed, Anusavice
Shenoy VK. Single tooth implants:
Pretreatment considerations and
pretreatment evaluation. J Interdiscip
Dentistry2012;2:149-157.